BNP Paribas Financial Markets
OKUR

BNP Paribas Financial Markets’s OnKure Therapeutics OKUR Stock Holding History

BNP Paribas Financial Markets’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16K Hold
281
– – ﹤0.01% 5460
2025
Q4 		$815 Sell
281
-83
-23% -$248 ﹤0.01% 5421
2025
Q3 		$1K Buy
364
+31
+9% +$77 ﹤0.01% 5236
2025
Q2 		$796 Buy
333
+36
+12% +$94 ﹤0.01% 5172
2025
Q1 		$1.28K Buy
297
+61
+26% +$343 ﹤0.01% 5039
2024
Q4 		$2.03K Buy
+236
New +$3.57K ﹤0.01% 5012

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BNP Paribas Financial Markets's OKUR Position: Q1 2026 in Review

BNP Paribas Financial Markets held its OnKure Therapeutics (OKUR) position steady in Q1 2026 at 281 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #5460.

BNP Paribas Financial Markets first reported a position in OKUR in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.03K in Q4 2024. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

  • BNP Paribas Financial Markets held 281 shares of OnKure Therapeutics worth $1.16K as of Q1 2026.
  • BNP Paribas Financial Markets left its OnKure Therapeutics share count unchanged in Q1 2026.
  • OnKure Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5460 holding.
  • BNP Paribas Financial Markets first reported a position in OnKure Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's OnKure Therapeutics position peaked at $2.03K in Q4 2024.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.